Banaras Hindu University, Institute of Medical Sciences, Department of Pediatrics, Division of Pediatric Nephrology, Varanasi, India.
Jawaharlal Postgraduate Institute of Medical Education and Research, Department of Biostatistics, Puducherry, India.
J Bras Nefrol. 2022 Jan-Mar;44(1):58-67. doi: 10.1590/2175-8239-JBN-2021-0043.
Treatment of nephrotic syndrome with corticosteroid can cause several side- effects including behavioral abnormalities. The objectives of the study were to observe the proportion of non-relapsers having persistence of behavioral abnormalities after completion of treatment of initial episode and compare the abnormalities with relapsers, and to determine risk factors for persistence.
Seventy-five children with a first episode of idiopathic nephrotic syndrome and 60 normal children were rated by parents for behavioral problems using the Child Behavior Checklist. The Parenting Stress Index was also evaluated. The children were rated before treatment and 12 and 36 weeks after.
Both relapsers and non-relapsers showed abnormalities in internalizing and externalizing domains at 12 weeks of steroid therapy. Non-relapsers had abnormal scores in the internalizing domain in 63.5 % and externalizing domain in 48.1% of cases at 36 weeks. Relapsers had abnormal scores in all the three behavior domains, but a significantly higher proportion of relapsers had abnormal scores regarding total behavior (65.2% vs 28.8%, p<0.01) and child domains (100% vs 57.7%, p<0.001) of Parenting Stress Index in comparison to non-relapsers at 36 weeks. Occurrence of relapse increased the risk (odds ratio 5.76, 95% CI 1.35-10.76, p< 0.001) for persistence of abnormal total behavior at 36 weeks follow-up.
Persistence of abnormalities was observed not only in relapsers but also in non-relapsers. Relapse was found to be a significant risk factor for persistence of abnormal behaviors in these patients.
皮质类固醇治疗肾病综合征可引起多种副作用,包括行为异常。本研究的目的是观察初始发作治疗完成后无复发者持续存在行为异常的比例,并与复发者比较异常情况,确定持续存在的危险因素。
对 75 例初发特发性肾病综合征患儿和 60 例正常儿童的家长采用儿童行为检查表(Child Behavior Checklist)进行行为问题评定,同时评估父母养育压力指数(Parenting Stress Index)。患儿在治疗前及治疗后 12、36 周进行评定。
皮质类固醇治疗 12 周时,复发组和非复发组患儿均出现内外向行为异常。36 周时,非复发组患儿在内向性和外向性行为领域的异常评分分别为 63.5%和 48.1%。复发组患儿在所有三个行为领域均存在异常评分,但在治疗后 36 周时,复发组患儿在总行为(65.2%比 28.8%,p<0.01)和儿童行为领域(100%比 57.7%,p<0.001)的养育压力指数异常评分比例显著高于非复发组。复发的发生增加了总行为在 36 周随访时持续异常的风险(比值比 5.76,95%可信区间 1.35-10.76,p<0.001)。
不仅在复发者中,而且在非复发者中也观察到异常的持续存在。复发是这些患者异常行为持续存在的一个显著危险因素。